Showing 1 - 7 results of 7 for search 'Sivakamavalli Jeyachandran', query time: 0.01s Refine Results
  1. 1
    Beta-adrenergic blocking agents in cutaneous and oral melanoma

    Beta-adrenergic blocking agents in cutaneous and oral melanoma by Sivakamavalli Jeyachandran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A Bayesian tool for optimizing sample size in phase I dose-finding trials for head and neck cancer

    A Bayesian tool for optimizing sample size in phase I dose-finding trials for head and neck cancer by Sivakamavalli Jeyachandran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx

    Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx by Sivakamavalli Jeyachandran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Interlink between pharyngeal radiation dose and long-term quality of life in HNSCC patients

    Interlink between pharyngeal radiation dose and long-term quality of life in HNSCC patients by Sivakamavalli Jeyachandran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Stereotactic body radiation therapy as initial treatment for head and neck cancer

    Stereotactic body radiation therapy as initial treatment for head and neck cancer by Sivakamavalli Jeyachandran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    AXL inhibition in treatment-resistant metastatic adenoid cystic carcinoma

    AXL inhibition in treatment-resistant metastatic adenoid cystic carcinoma by Sivakamavalli Jeyachandran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes

    Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes by Sivakamavalli Jeyachandran

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: